The Fat and the Furiex: Could FDA Wins Help Contrave Bid?
The FDA's marketing clearance of three alogliptin-containing drugs for Type II diabetes as adjuncts to diet and exercise sent Furiex Pharmaceuticals Inc. on a happy Wall Street ride, at the same time causing onlookers to speculate about what the approvals might mean for the obesity candidate Contrave, which like alogliptin is partnered with Takeda Pharmaceutical Co. Ltd.
Suite: 1100 | Atlanta, Georgia 30346, USA
In the U.S. and Canada: 1-855-260-5607
Outside the U.S.: 1-646-822-4549
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter